首页> 外文期刊>Oncology reports >Effects and mechanism of RhoC downregulation in suppressing ovarian cancer stem cell proliferation, drug resistance, invasion and metastasis
【24h】

Effects and mechanism of RhoC downregulation in suppressing ovarian cancer stem cell proliferation, drug resistance, invasion and metastasis

机译:RhoC下调抑制卵巢癌干细胞增殖,耐药性,侵袭和转移的作用及其机制

获取原文
获取原文并翻译 | 示例
           

摘要

Cancer stem cells are considered to be the root cause of tumor initiation, metastasis, recurrence and therapeutic resistance. Recent studies have reported that RhoC plays a critical role in regulating cancer stem cells; however, its function in ovarian cancer stem cells (OCSCs) remains unknown. The ovarian cancer cell line A2780, and the paclitaxel-resistant A2780 cell line (A2780-PTX) were obtained. A2780 cells were used to isolate and identify the highly invasive A2780-PM cells, and A2780-PTX cells were used to isolate and identify the highly drug-resistant and highly invasive A2780-PTX-PM cells by Transwell assay. MTT, Transwell and wound healing assays were used to compare the differences in cell proliferation, invasion and migration ability among the four cell lines. Immunofluorescence was used to detect the expression of stem cell markers CD117 and CD133. OCSCs were sorted by flow cytometry. Following si-RhoC transfection of the OCSCs, cell proliferation, drug resistance, invasion and migration ability and RhoC, CD117 and CD133 expression levels were assayed. RT-PCR was used to assess RhoC, CD117, CD133 and matrix metalloproteinase 9 (MMP9) mRNA expression levels. A2780-PM and A2780-PTX-PM cells exhibited higher cell proliferation, drug resistance, and invasion and migration ability than the A2780 and A2780-PTX cell lines. Furthermore, CD133 and CD117 expression levels were higher in the A2780-PM and A2780-PTX-PM cells than levels in the A2780 and A2780-PTX cells. Transfection of si-RhoC in OCSCs suppressed the proliferation, drug resistance, invasion, migration and CD117 and CD133 expression levels. Furthermore, the expression levels of RhoC, CD117, CD133, MDR1, and MMP9 mRNA were downregulated in the transfected population. Taken together, our results demonstrated that RhoC downregulation may inhibit the proliferation, drug resistance, invasion and migration of OCSCs, and RhoC may play an important role in the formation of OCSCs.
机译:癌症干细胞被认为是肿瘤起始,转移,复发和治疗抗性的根本原因。最近的研究报道,RhoC在调节癌症干细胞中起着至关重要的作用。然而,其在卵巢癌干细胞(OCSCs)中的功能仍然未知。获得了卵巢癌细胞系A2780和耐紫杉醇的A2780细胞系(A2780-PTX)。通过Transwell测定法,将A2780细胞用于分离和鉴定高度侵入性的A2780-PM细胞,并将A2780-PTX细胞用于分离和鉴定高度耐药性和高侵入性的A2780-PTX-PM细胞。使用MTT,Transwell和伤口愈合测定法比较四种细胞系之间细胞增殖,侵袭和迁移能力的差异。免疫荧光用于检测干细胞标记CD117和CD133的表达。通过流式细胞术对OCSC进行分类。在OCSC的si-RhoC转染后,测定了细胞增殖,药物抗性,侵袭和迁移能力以及RhoC,CD117和CD133表达水平。 RT-PCR用于评估RhoC,CD117,CD133和基质金属蛋白酶9(MMP9)mRNA表达水平。与A2780和A2780-PTX细胞系相比,A2780-PM和A2780-PTX-PM细胞表现出更高的细胞增殖,耐药性以及侵袭和迁移能力。此外,在A2780-PM和A2780-PTX-PM细胞中,CD133和CD117表达水平高于在A2780和A2780-PTX细胞中。在OCSC中转染si-RhoC可抑制增殖,耐药性,侵袭,迁移以及CD117和CD133表达水平。此外,在转染的人群中,RhoC,CD117,CD133,MDR1和MMP9 mRNA的表达水平下调。两者合计,我们的结果表明RhoC下调可能抑制OCSC的增殖,耐药性,侵袭和迁移,并且RhoC可能在OCSC的形成中起重要作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号